SS Innovations Raises $18.6 Million in Private Placement for Surgical Robotics Expansion
SS Innovations International Inc. completed a private placement on March 6, raising approximately $18.6 million. The company sold 5,774,839 shares, with executives purchasing 1,300,006 shares. The funds will support working capital and corporate purposes, including global expansion. The FDA is expected to review the 510(k) notification for the SSi Mantra system by mid-2026.

SS Innovations International Inc. completed a private placement of common stock on March 6, generating $18.6 million in gross proceeds. The company sold 5,774,839 shares in two tranches, with executives purchasing 1,300,006 shares for $5.2 million.
Manipal Global Health Services led existing and new investors in purchasing 4,474,833 shares at $3.00 per share. The net proceeds will be used for working capital and global expansion. The FDA is expected to review the 510(k) notification for the SSi Mantra surgical robotic system by mid-2026. Additionally, a $2.5 million investment will incur a $175,000 cash commission and warrants for 41,667 shares.




Comments